| Wed, Jan 27, 2010 |
| • |
MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD
EDGAR Online (Wed, Jan 27)
|
| • |
Molecular Insight Announces Updates to Board of Directors
Marketwire (Wed, Jan 27)
|
| Mon, Jan 11, 2010 |
| • |
UPDATE - Molecular Insight cuts job, shares fall
at Reuters (Mon, Jan 11)
|
| • |
Biotech's Latest Failed Trials, Missed Targets
at Seeking Alpha (Mon, Jan 11)
|
| Thu, Jan 7, 2010 |
| • |
Molecular Insight Pharmaceuticals Announces Personnel Reduction to Align Operations With Development Activities
Marketwire (Thu, Jan 7)
|
| Thu, Dec 17, 2009 |
| • |
Cashing In on Obamacare
at Motley Fool (Thu, Dec 17)
|
| Fri, Dec 11, 2009 |
| • |
Molecular Insight Pharma downgraded by Jefferies & Co
Briefing.com (Fri, Dec 11)
|
| Thu, Dec 3, 2009 |
| • |
MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibi
EDGAR Online (Thu, Dec 3)
|
| Tue, Nov 24, 2009 |
| • |
MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD
EDGAR Online (Tue, Nov 24)
|
| • |
Molecular Insight Pharmaceuticals Announces Changes to Board
Marketwire (Tue, Nov 24)
|
| Fri, Nov 13, 2009 |
| • |
MOLECULAR INSIGHT PHARMACEUTICALS, INC. Financials
EDGAR Online Financials (Fri, Nov 13)
|
| Wed, Nov 11, 2009 |
| • |
Molecular Insight Pharmaceuticals to Present at Lazard Capital Markets Annual Healthcare Conference
Marketwire (Wed, Nov 11)
|
| Mon, Nov 9, 2009 |
| • |
Molecular Insight Pharmaceuticals, Inc Earnings Call scheduled for 4:30 pm ET today
CCBN (Mon, Nov 9)
|
| • |
MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Even
EDGAR Online (Mon, Nov 9)
|
| • |
Molecular Insight Pharmaceuticals Reports Third Quarter 2009 Financial Results
Marketwire (Mon, Nov 9)
|
| • |
MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
|
| Mon, Oct 26, 2009 |
| • |
Molecular Insight Pharmaceuticals, Inc. to Report Third Quarter Financial Results on November 9, 2009
Marketwire (Mon, Oct 26)
|
| Wed, Oct 21, 2009 |
| • |
Molecular Insight Pharmaceuticals Finalizes Onalta(TM) Manufacturing and Supply Agreements
Marketwire (Wed, Oct 21)
|
| Thu, Oct 15, 2009 |
| • |
Venture Capitalists Resist Regulatory Calls
at TheStreet.com (Thu, Oct 15)
|
| Mon, Oct 5, 2009 |
| • |
Molecular Insight Pharmaceuticals Presents Azedra(TM) 12-Month Efficacy Data From Phase I Clinical Trial in Neuroendocrine Tumors
Marketwire (Mon, Oct 5)
|
| Older Headlines |
|
|
|
|
Help
Headlines
